THRX posts

Feed

Analyst Calls: BBY, BF.B, EEP, K, ORLY, PGR, SLB, SWK, TAP ...

Analyst Upgrades

  • Stephens upgraded Schlumberger (SLB) to overweight from equal weight with an $80 price target, citing valuation and the company's international activity.
  • Roth Capital upgraded Synutra International (SYUT) to buy from hold, citing the company's improved outlook, increased market share and valuation. The firm has a $27 target on shares.
  • Oppenheimer upgraded Progressive (PGR) to perform from underperform as it believes the company's focus on growth could move shares higher in the near-term.
  • Inergy Holdings (NRGP) was upgraded to buy from hold at Wunderlich.
  • Best Buy (BBY) was upgraded to hold from sell at Societe Generale.
  • Vale SA (VALE) was upgraded to buy from hold at Canaccord.

Continue reading Analyst Calls: BBY, BF.B, EEP, K, ORLY, PGR, SLB, SWK, TAP ...

Market highlights for next week: YUM, AA, COST, PEP to report

Monday October 8
  • PDUFA date for Theravance Inc's (NASDAQ: THRX) Telavancin for complicated skin and soft tissue infections caused by gram-positive bacteria
Tuesday October 9
Wednesday October 10
Thursday October 11
Friday October 12

Analyst initiations: AKAM, BBBY, MFE and WSM

MOST NOTEWORTHY: VMware (VMW), Bed, Bath & Beyond (BBBY), Williams-Sonoma (WSM), Landstar System (LSTR) and Acadia Pharmaceuticals (ACAD) were the noteworthy initiations:
  • Robert W. Baird initiated coverage on VMware (NYSE: VMW) with a Neutral rating citing valuation.
  • Citigroup started Bed Bath & Beyond (NASDAQ: BBBY) with a Hold rating, and cited the increasing competitive environment, slowing square footage growth and the weak housing market.
  • Citigroup started Williams-Sonoma (NYSE: WSM) with a Sell rating and said the company has an inventory glut that could lead to markdown risk, there is raw material price inflation, and the weak housing market remains a material risk.
  • Wachovia is cautious on Landstar System's (NASDAQ: LSTR) near-term growth rates and difficult end markets, starting shares with a Market Perform rating.
  • Deutsche is positive on the potential of Acadia Pharmaceutical's (NASDAQ: ACAD) ACP-103 in schizophrenia, starting shares with a Buy rating...
OTHER INITIATIONS:
  • Raymond James initiated Akamai (NASDAQ: AKAM) with an Outperform and resumed coverage of McAfee (NYSE: MFE) with an Outperform rating.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Symbol Lookup
IndexesChangePrice
DJIA-74.9212,454.83
NASDAQ-1.852,837.53
S&P 500-2.861,317.82

Last updated: May 27, 2012: 05:24 PM

Hot Stocks

General Electric

19.20-0.05(-0.26)

Alcoa

8.630.00(0.00)

Apple Inc

562.29-3.03(-0.54)

Google Inc 'A'

591.53-12.13(-2.01)

Bank of America

7.15+0.01(+0.14)

Wal-Mart Stores

65.31+0.24(+0.37)

Exxon Mobil Corp

82.08-0.53(-0.64)

Ford

10.60+0.01(+0.09)

Citigroup

26.47-0.19(-0.71)

IBM

194.30-1.79(-0.91)

Yahoo

15.36+0.01(+0.07)

Starbucks

54.56-0.20(-0.37)

Microsoft

29.06-0.01(-0.03)

Home Depot

49.44-0.27(-0.54)

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

Page Loaded in 1338153889925 ms.